Status and phase
Conditions
Treatments
About
The purpose of this study is to see if the investigators can improve the treatment of this type of cancer. They want to find out what effects, good and/or bad, giving heated chemotherapy into the belly, known as hyperthermic intraperitoneal chemotherapy (HIPEC), has on the patient and this type of cancer.
The goal of HIPEC is to expose any cancer left in the abdomen after surgery to high doses of chemotherapy. The chemotherapy is heated in the hope that this will make it easier for it to get into and kill the cancer cells. The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria for Eligibility Prior to Surgery:
Inclusion Criteria for Eligibility Post-Surgery:
Exclusion criteria
Exclusion Criteria for Eligibility Prior to Surgery:
Exclusion Criteria for Eligibility Post-Surgery:
Primary purpose
Allocation
Interventional model
Masking
99 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal